Vertex Pharmaceuticals (VRTX) Stock Price
$426.4 0%
to add to portfolio
AI Score
-
Alternative
8 -
Fundamental
8 -
Technical
6
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Vertex Pharmaceuticals, AI stock picks, stock alerts and much more.
VRTX AI Stock Analysis
Financial Performance
The financial performance of Vertex Pharmaceuticals has been strong and consistent, with revenue growth of 10.1% YoY and a gross profit increase of 10.7% YoY. The operating income profit witnessed a significant surge by 131.7% from the previous quarter and up by 16.4% YoY, indicating efficient operations management and cost control measures in place.
Stock Price
The stock price is currently trading at $453.2, marking an increase of 6.8% over the past month and an overall annual gain of 8.5%. However, the stock is slightly below its 200-day moving average ($461.68), suggesting cautious investor sentiment in the medium term despite recent gains.
Alternative Data Signals
Website traffic trends indicate a robust increase in interest towards the company with a monthly visitor count growing by 19.2%. Job postings have also seen decent growth (13.7%), implying potential expansion plans or increased workload within the company which could translate into future growth prospects for Vertex Pharmaceuticals.
A very positive business outlook reported by employees suggests high morale which could contribute to productivity improvements while increasing social media followers on Instagram indicates improved brand visibility.
Conclusion
In conclusion, considering stable financial performance, positive alternative data signals, but slightly cautious investor sentiment reflected in stock price trends; our AI analysis leans towards a moderately bullish view on Vertex Pharmaceuticals' stock.
Note: This AI Stock Analysis is based on data as of February 13. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Vertex Pharmaceuticals (VRTX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Vertex Pharmaceuticals (VRTX), currently trading at $426.4, will... Sign up to access price prediction.
About VRTX
-
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis.
-
Symbol
VRTX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
109.3B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$20.97 2.2% |
7 |
 |
Inovio Pharmaceuticals INO |
$2.22 4.7% |
2 |
 |
Moderna MRNA |
$26.85 2.3% |
4 |
 |
Anavex Life Sciences AVXL |
$9.35 0.00% |
5 |
 |
BridgeBio Pharma BBIO |
$53.24 2.1% |
5 |
News
VRTX Alternative Data
Web Traffic
Vertex Pharmaceuticals receives an estimated 381224 monthly visitors to vrtx.com.
-
Web Traffic
381224
-
Change from Previous Month
8.3%
-
3 Month Change
20%
-
YoY Change
20%
Stocktwits Mentions
Vertex Pharmaceuticals has been mentioned an estimated 37 times on Stocktwits over the last 24 hours.
-
Stocktwits Mentions
37
-
Daily Change
5.7%
-
1 Month Change
94.7%
Twitter Followers
Vertex Pharmaceuticals has 70,766 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.1% over the last month.
-
Twitter Followers
70766
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0%
-
YoY Change
0%
Instagram Followers
Vertex Pharmaceuticals has 13,087 Instagram Followers on its main Instagram account, up by 1.6% over the last month.
-
Instagram Followers
13087
-
Daily Change
0%
-
1 Month Change
1.6%
-
3 Month Change
2.9%
-
YoY Change
2.9%
Youtube Subscribers
Vertex Pharmaceuticals has 3,150 subscribers on its main Youtube channel, up by 5.4% over the last month.
-
Youtube Subscribers
3150
-
Daily Change
0.3%
-
1 Month Change
5.4%
-
3 Month Change
12.1%
-
YoY Change
12.1%
LinkedIn Followers
516,902 are following Vertex Pharmaceuticals on LinkedIn, up by 2.6% over the last month.
-
LinkedIn Followers
516902
-
Daily Change
0.1%
-
1 Month Change
2.6%
-
3 Month Change
7.6%
-
YoY Change
7.6%
Job Postings
Vertex Pharmaceuticals currenly has an estimated 287 open job postings, up by 42.1% over the last month.
-
Job Postings
287
-
Daily Change
12.5%
-
1 Month Change
42.1%
-
3 Month Change
64.9%
-
YoY Change
64.9%
LinkedIn Employees
According to LinkedIn, Vertex Pharmaceuticals has 6,083 employees, up by 0.7% over the last month.
-
LinkedIn Employees
6083
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
0.8%
-
YoY Change
0.8%
Reddit Mentions
Vertex Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Vertex Pharmaceuticals is 88 out of 100 (very bullish).
-
Business Outlook
88
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Sentiment
The sentiment Score for Vertex Pharmaceuticals is 37 out of 100, which represents a bearish sentiment.
-
Reddit Sentiment
36.625
-
1 Month Change
0%
News Mentions
Vertex Pharmaceuticals was mentioned 3 times in the news yesterday.
-
News Mentions
3
-
Daily Change
40%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
VRTX Financials
VRTX Key Metrics
-
Total Revenue
$2.8B
-
Net Income
$646.3M
-
Earnings per Share
$2.52
-
Free cash flow
$492M
-
EBITDA
$630.1M
-
EBITDA Ratio
0.227456
-
Total Assets
$22.9B
VRTX 2-year Revenue & Income
VRTX 2-year Free Cash Flow
VRTX Technicals
VRTX SMA
VRTX RSI
FAQ
What's the current price of Vertex Pharmaceuticals (VRTX) Stock?
The price of an Vertex Pharmaceuticals (VRTX) share is $426.4.
What's the market cap of Vertex Pharmaceuticals?
The current market cap of Vertex Pharmaceuticals is 109.3B.
What are some stocks similar to Vertex Pharmaceuticals (VRTX) that investors often compare it to?
Vertex Pharmaceuticals (VRTX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Vertex Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Vertex Pharmaceuticals' stock price to be around $472.7 in 2026. Starting from the current price of $426.4, this represents a 10.8% change in price, indicating a bullish outlook for the stock.
How to buy Vertex Pharmaceuticals (VRTX) Stock?
Vertex Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Vertex Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.